[¹³C,²H₃]-Belzutifan Standards for LC-MS/MS

[¹³C,²H₃]-Belzutifan Standards for LC-MS/MS

Catalog Number:
SILS567257SHI
Mfr. No.:
SHI-C10740
Price:
Inquiry
  • Size:
    Quantity:
    Add to Cart:
    Add to Cart
      • Overview

        • Belzutifan is intended for Pharmaceuticals applications. It is an inhibitor of hypoxia-inducible factor 2a used in the treatment of certain cancers and was approved in december 2023 by the FDA for patients with advanced renal cell carcinoma. All information about [13C,2H3]-Belzutifan is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis.

          Please contact us at for specific academic pricing.

      • Properties
        • Alternative Name
          Belzutifan-13C,D3
          CAS Number
          1672668-24-4 unlabeled
          Molecular Formula
          C17H12F3NO4S
          Molecular Weight
          387.35 g/mol
          Purity
          0.95
          Solubility
          refer to COA
          Other Properties
          Min. isotopic enrichment: 99%13 C, 98%2 H
          Stability: ≥ 1 year

          * For research use only.

    We Also Recommend

    [²H₅]-Atorvastatin calcium salt, CAS Number: 265989-43-3

    [²H₅]-Atorvastatin calcium salt, CAS Number: 265989-43-3

    [¹³C₆]-Canagliflozin Standards for LC-MS/MS

    [¹³C₆]-Canagliflozin Standards for LC-MS/MS

    [¹³C₆]-Empagliflozin Standards for LC-MS/MS

    [¹³C₆]-Empagliflozin Standards for LC-MS/MS